JOHNSON & JOHNSON COM USD1 revenue breakdown overview

JOHNSON & JOHNSON COM USD1 revenue for the last year amounted to 85.16 B USD, the most of which — 54.76 B USD — came from its highest performing source at the moment, Innovative Medicine, the year earlier bringing 52.56 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought JOHNSON & JOHNSON COM USD1 46.44 B USD, and the year before that — 48.58 B USD.